Atlas Trials

Systemic Juvenile Idiopathic Arthritis

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Systemic Juvenile Idiopathic Arthritis

RecordFirmDate
Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection (NCT05027373)Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2021-08-13
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) (NCT04088396)Eli Lilly and Company2020-02-12
An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) (NCT01676948)Novartis Pharmaceuticals2013-01-01
Ultrasonography in Juvenile Idiopathic Arthritis (NCT01304420)University of Aarhus2009-10-01
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. (NCT00891046)Novartis Pharmaceuticals2009-09-01
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA) (NCT00886769)Novartis Pharmaceuticals2009-07-01
Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA) (NCT01803321)Regeneron Pharmaceuticals2005-11-01
Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) (NCT00144612)Chugai Pharmaceutical2004-07-01
Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) (NCT00144599)Chugai Pharmaceutical2004-05-01

Track Systemic Juvenile Idiopathic Arthritis automatically

Every clearance here is in the API, with alerts when new ones post.